Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health said its “digital first strategy” is driving increases in its online customer base and visits to its MinuteClinic as the nation's largest retail pharmacy chain repositions itself as a community health destination. The comments come as the Rhode Island-based company reported second-quarter earnings results Wednesday (Aug.

CVS Q2: ‘Digital First Approach' Drives Boost in Convenience, Community Health

Other companies, including Walgreens, Walmart and Amazon, are opening or investing in doctor offices.

CVS says it plans to get into primary care by year end

CVS Health (CVS) delivered earnings and revenue surprises of 11.11% and 5.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates

The company says second-quarter sales rose 11% from a year earlier to $80.6 billion.

CVS Posts Earnings Beat and Raises Guidance. The Stock Moves Higher.

CVS Health Corp. shares CVS, -0.68% jumped 2.2% in premarket trade Wednesday, after the drug-store chain and medical benefits company posted better-than-expected second-quarter earnings and raised guidance. CVS had net income of $2.951 billion, or $2.23 a share, for the quarter, up from $2.783 billion, or $2.10 a share, in the year-earlier period.

CVS shares up 2.2% premarket after earnings beat and company raises guidance

The health-care company said it now expects adjusted earnings per share for the full year to come in between $8.40 and $8.60.

CVS Health raises full-year forecast after beating second-quarter expectations

CVS Health Corp on Wednesday raised its full-year profit forecast after strength in its insurance business and sales of COVID-19 over-the-counter test kits helped the company report a 6% jump in second-quarter earnings.

CVS Health raises forecast as insurance business, OTC COVID tests boost Q2 profit

WOONSOCKET, R.I. , Aug. 3, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2022.

CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE

We expect CVS stock to trade higher post the results announcement, with Q2 revenue and earnings likely being above the consensus estimates, primarily driven by the post-pandemic recovery in the retail business.

What To Expect From CVS Health's Q2?

Moderna

Pfizer

Health care's potential to do better in both up and down markets makes it a valuable part of a long-term investment strategy.

3 Health Care Stocks in Great Financial Health

Bottom-line beats are the name of the game for CVS; the company hasn't reported quarterly EPS below the Zacks Consensus EPS Estimate since 2015.

CVS Health Q2 Preview: Can the Earnings Streak Continue?

CVS has attracted some controversy recently with lawsuits and product recalls. Still, there are reasons to remain bullish about this stock, as we'll explore.

Should CVS Health Be in Your Portfolio?

The New York Attorney General on Thursday sued CVS Health Corp, saying the pharmacy chain violated antitrust laws and hurt New York safety-net hospitals and healthcare providers.

New York Attorney General sues CVS Health for violating antitrust laws

Walgreens

The product – distributed nationwide to wholesale and retailer outlets such as CVS, Kroger, Walgreens, Harris Teeter, Rite Aid and Walmart – is used for relief of occasional constipation.

Laxatives sold at CVS, Walgreens recalled due to contamination

Eugenio Zuccarelli, a data scientist at CVS Health, shared his thoughts on some of the top trends he sees in healthcare AI right now.

4 healthcare AI trends: CVS Health data scientist shares details

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

These are both market-beating stocks that have done better than the S&P this year.

2 Top Dividend Stocks Trading at Incredibly Cheap Valuations

Although room for improvement exists in share price performance, CVS Health's emerging one-stop neighborhood health care model and attractively-priced stock offer a compelling buy-and-hold argument. Since adding the stock to our family portfolio in early 2018, I remain bullish on CVS's value proposition, shareholder yields, fundamentals, valuation, and downside risks.

CVS Health: One-Stop Health Care Juggernaut

The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and WBA are likely to gain the most.

2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges

Foot Locker

Stock market bargain hunters are a little like baseball scouts, trying to find talent that other teams have overlooked.

Foot Locker and CVS Look Good on Price-to-Sales

CVS Health's (CVS) investments in constructing affordable housing units in Denver, Fresno, Nashville and San Antonio seem encouraging.

CVS Health (CVS) Pharmacy Claims Volume Grows, Margin Woes Stay

WOONSOCKET, R.I. , July 13, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 3, 2022, at 8:00 a.m.

CVS Health to hold second quarter 2022 earnings conference call

2022 Health Care Insights Study finds consumers are seeking deeper, more personalized provider relationships that deliver whole-person outcomes WOONSOCKET, R.I. , July 11, 2022 /PRNewswire/ -- The CVS Health (NYSE: CVS) 2022 Health Care Insights Study, released today, reveals that U.S. consumers—many of whom delayed care over the past several years because of COVID-19—are now eager to restart their health and wellness journeys.

Consumers Want a More Connected, Personal Health Care Experience, New CVS Health Study Reveals

WOONSOCKET, R.I. , July 8, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) has appointed Tilak Mandadi as Executive Vice President and to the newly created role of Chief Data, Digital and Technology Officer, effective July 25.

CVS Health Names Tilak Mandadi Executive Vice President and Chief Data, Digital and Technology Officer

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why CVS Health (CVS) Could Beat Earnings Estimates Again

Many income investors are drawn to healthcare stocks like CVS and Walgreens for their stable dividends. Indeed, both stocks have demonstrated long-term dividend consistency and growth, and Walgreens is a dividend champion with 46 years of consecutive raises.

News for CVS Health Stock (CVS)